Skip to main content
. 2018 Jan 29;6:9. doi: 10.1186/s40425-018-0319-9

Fig. 1.

Fig. 1

Swimmer’s Plot of Time on Treatment for 35 Evaluable Patients. Patient 5 and patient 10 received a single dose of nivolumab. Patient 31 and patient 34 had documented PR after discontinuation of nivolumab due to intolerance